STKH
$3.89
+$0.99 (34.38%)+34.38%
OpenLoading chart...
IndexN/A
Market Cap0.00B
Enterprise Value0.00B
Income$-0.00B
Sales$0.00B
EmployeesN/A
P/E-2.02
P/S0.00
P/B0.87
P/C-0.56
EV/EBITDA-0.11
EV/SalesN/A
EPS (ttm)-1.91
EarningsN/A
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Volume28.09M
Shs Outstand0.00B
Change34.38%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.00K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $49.12K | $410.29K |
| Cost of Revenue | $22.00K | $450.83K | $382.50K | $680.47K | $214.49K | $20.06K | $70.36K | $70.78K |
| Gross Profit | $-12.00K | $-450.83K | $-382.50K | $-680.47K | $-214.49K | $-20.06K | $-21.24K | $339.51K |
| Gross Margin | -120.00% | N/A | N/A | N/A | N/A | N/A | -43.24% | 82.75% |
| Operating Expenses | $8.46M | $13.69M | $16.65M | $16.55M | $18.33M | $2.31M | $1.41M | $1.39M |
| Operating Income | $-8.48M | $-14.14M | $-17.03M | $-17.23M | $-18.54M | $-2.33M | $-1.43M | $-1.06M |
| Operating Margin | -84760.00% | N/A | N/A | N/A | N/A | N/A | -2911.90% | -257.22% |
| Net Income | $-8.52M | $-16.86M | $-21.77M | $-18.04M | $-18.53M | $-3.13M | $-1.59M | $-1.10M |
| Net Margin | -85210.00% | N/A | N/A | N/A | N/A | N/A | -3230.28% | -268.30% |
| EPS (Basic) | $-100.00 | $-330.00 | $-550.00 | $-165.00 | $-1540.00 | $-110.00 | $-531.76 | $-430.00 |
| EBITDA | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Assets | $7.79M | $10.82M | $15.32M | $40.65M | $17.47M | $2.18M | $3.44M | $4.87M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $3.74M | $4.94M | $7.43M | $3.03M | $1.84M | $325.75K | $1.02M | $2.49M |
| Non-Equity Reserves | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Shareholders Equity | $4.05M | $5.88M | $9.40M | $37.62M | $15.63M | $1.86M | $2.41M | $2.39M |
| Accumulated Minority Interest | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $4.05M | $5.88M | $9.40M | $37.62M | $15.63M | $1.86M | $2.41M | $2.39M |
| Total Liabilities & Stockholders Equity | $7.79M | $10.82M | $15.32M | $40.65M | $17.47M | $2.18M | $3.44M | $4.87M |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-8.52M | $-16.86M | $-21.77M | $-18.04M | $-18.53M | $-3.13M | $-1.59M | $-1.10M |
| Depreciation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Operating Activities | $-8.46M | $-12.73M | $-14.31M | $-13.96M | $-3.83M | $-741.02K | $-1.01M | $-457.76K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Company coverage
Latest news
Steakholder Foods Ltd. Announces Up To $10.5 Million Private PlacementGlobeNewswire Inc. Steakholder Foods Announces ADS Ratio AdjustmentGlobeNewswire Inc. Steakholder Foods® Shares Letter from the CEO, Arik KaufmanGlobeNewswire Inc. Steakholder Foods® Continues Building Strategic Partnerships, Unveils New Product Offering in Collaboration with Sherry HerringGlobeNewswire Inc. Top 4 Risk Off Stocks You'll Regret Missing In Q4Benzinga Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionBenzinga Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving PremarketBenzinga Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's SessionBenzinga
Show 12 more stories
Steakholder Foods® Announces US$6 Million Registered Direct OfferingGlobeNewswire Inc. Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionBenzinga Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day SessionBenzinga US Stocks Lower Following Initial Jobless Claims ReportBenzinga Nasdaq Down 50 Points; US Home Price Index Rises In FebruaryBenzinga US Stocks Mostly Lower; Nasdaq Down 50 PointsBenzinga Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving PremarketBenzinga Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day SessionBenzinga Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving PremarketBenzinga Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From YesterdayBenzinga Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day SessionBenzinga US Stocks Open Lower As Dow Drops 100 PointsBenzinga
Insider Trading
No insider trades found for STKH.
Company
About the company
MeaTech 3D Ltd., an advanced food technology firm, is dedicated to pioneering innovative methods for producing cultivated meat, thereby eliminating the necessity for animal slaughter. Central to its research and development is a sophisticated three-dimensional bioprinter. This device precisely deposits layers of specialized stem cells, structural scaffolding materials, and essential cell nutrients to construct structured cultured meat with a defined three-dimensional form. The company plans to commercialize its groundbreaking production technology by licensing it to other entities. Additionally, it intends to supply crucial complementary products such as proprietary cell lines, specialized printheads, bioreactors, and incubators. Its comprehensive service portfolio will include technology deployment, thorough training, and ongoing engineering assistance, which will be provided directly or through contractors to food processing and retail businesses. The company's headquarters are situated in Rehovot, Israel.
Discover more
You may be interested in